MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS: …
Working document QAS/14.583/Rev.1 page 3 43 BACKGROUND 44 Over the course of time and especially in view of the implementation of the existing 45 guidelines 1 the users have indicated that there was a need to review and update certain 46 requirements.
Download MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS: …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Quality control methods - World Health Organization
apps.who.intWHO Library Cataloguing-in-Publication Data Quality control methods for herbal materials. Updated edition of Quality control methods for medicinal plant materials, 1998 …
3AFETY'LOSSARY - International Atomic Energy Agency
www-pub.iaea.orgThe following States are Members of the International Atomic Energy Agency: The Agency’s Statute was approved on 23 October 1956 by the Conference on the Statute of
Program of Priestly Formation - United States Conference ...
www.usccb.orgThe document Program of Priestly Formation (fifth edition) was developed by the Committee on Priestly Formation of the United States Conference of Catholic Bishops (USCCB). It was approved by the full body of bishops at its June 2005
STABILITY TESTING OF ACTIVE PHARMACEUTICAL …
www.who.intWorking document QAS/17.694 page 3 Introduction and background36 37 38 The Stability testing of active pharmaceutical ingredients and finished 39 pharmaceutical products was published as Annex 2 in the WHO Technical 40 Report Series, No. 953, 2009 (1). 41 42 These regulatory guidelines seek to exemplify the core stability data package 43 required for registration of active pharmaceutical ...
Comments concerning revised texts published in Supplement 9
www.edqm.eu2 © Pharmeuropa | Useful information | October 2017 3.1.5. Polyethylene with additives for containers for parenteral preparations and for ophthalmic preparations
Comments concerning revised texts published in Supplement 9
www.edqm.eu© Pharmeuropa | Useful information | December 2017 1 Comments concerning revised texts published in Supplement 9.5 The following information details the technical ...